Is there a correlation between spirometry parameters (e.g., forced expiratory flow 25‑75% and FEV1/FVC ratio) and small‑airway disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, there is a clear correlation between spirometry parameters and small airway disease

Small airway parameters, particularly FEF25-75% (forced expiratory flow between 25% and 75% of vital capacity), demonstrate significant correlation with small airway disease and provide critical diagnostic information beyond conventional spirometry measures like FEV1 and FEV1/FVC ratio.

Understanding the Correlation

The European Respiratory Society guideline 1 establishes the foundational framework: early small airway obstruction manifests as slowing in the terminal portion of the spirogram, creating a characteristic concave shape on the flow-volume curve. This is quantitatively reflected in disproportionate reductions in FEF75% and FEF25-75% compared to FEV1. However, the guideline appropriately cautions that these mid-range flow abnormalities are "not specific for small airway disease in individual patients" 1.

Clinical Evidence Supporting the Correlation

Recent high-quality research substantially strengthens the case for using small airway parameters:

  • In a large Chinese population study of 26,658 individuals, combining small and large airway parameters achieved the best predictive accuracy for airflow limitation (AUC 0.90) and bronchodilator responsiveness (AUC 0.72) 2. Critically, among those with normal FVC, 3.7-4.5% showed normal FEV1/FVC but impaired small airway parameters, and 6.8-7.0% had normal FEV1 but impaired FEF25-75%, FEF75%, and FEF50% 2.

  • In symptomatic ever-smokers, low FEF25-75% was present in 99.9% of patients with airflow limitation and 50% of those without conventional airflow limitation 3. Even in the absence of airflow limitation by traditional criteria, low FEF25-75% was associated with lower FEV1 and FEV1/FVC, suggesting it identifies early pathological lung damage 3.

  • The SPIROMICS cohort study demonstrated that lower FEF25-75% correlated with increased emphysema, functional small airways disease, total lung capacity, and bronchodilator responsiveness—even after adjusting for FEV1 or FVC 4. This indicates FEF25-75% provides independent information about disease manifestation.

Specific Correlations by Disease State

In Asthma

In asthmatic children with normal FEV1, FEF25-75% showed superior correlation with bronchodilator responsiveness and methacholine PC20 compared to FEV1 or FEV1/FVC 5. A threshold of FEF25-75% at 65% predicted had 90% sensitivity and 67% specificity for detecting 20% FEV1 reversibility after bronchodilator 5. FEF25-75% reversibility demonstrated sensitivity of 0.59 compared to only 0.31 for FEV1 reversibility at the >12% cutoff 6.

In Allergic Rhinitis

FEF25-75% reduction (defined as <80% predicted) showed strong association with allergic parameters including nasal symptoms and eosinophils, even with normal FEV1, FVC, and FEV1/FVC 7. The mean FEF25-75% was 70.3% in those with small airway dysfunction versus 108.0% in those with preserved function 7.

In COPD/Smoking

FEF25-75% decreased progressively with airflow limitation severity and linked anatomic pathology (emphysema, air trapping) to deranged physiology 4.

Critical Caveats

  1. Lack of specificity: While sensitive for detecting small airway abnormalities, reduced FEF25-75% is not specific to any particular disease process 1.

  2. High variability: Small airway parameters have greater measurement variability than FEV1, requiring careful quality control.

  3. Reference value dependency: Interpretation depends heavily on appropriate reference equations for the population studied.

  4. Not a standalone measure: The guideline framework emphasizes that small airway parameters should complement, not replace, conventional spirometry 1.

Practical Algorithm for Interpretation

When evaluating spirometry for small airway disease:

  1. First assess conventional parameters: FEV1/FVC ratio to identify obstruction, FEV1 for severity
  2. If FEV1 and FEV1/FVC are normal but clinical suspicion exists: Examine FEF25-75%, FEF50%, and FEF75%
  3. Look for disproportionate reduction: FEF25-75% reduced >20% more than FEV1 suggests small airway involvement
  4. Assess flow-volume curve morphology: Concave shape in expiratory limb supports small airway disease
  5. Consider bronchodilator testing: FEF25-75% reversibility >12% has higher sensitivity than FEV1 reversibility for detecting reversible obstruction 6

The evidence strongly supports that small airway parameters correlate with small airway disease and identify early pathology missed by conventional spirometry alone, though they should be interpreted within the complete clinical context 2, 3, 4.

References

1
Guideline

interpretative strategies for lung function tests.

European Respiratory Journal, 2005

Related Questions

What is the Forced Expiratory Flow (FEF) 25-75?
Can spirometry parameters such as forced expiratory volume in 3 seconds (FEV3), forced expiratory volume in 6 seconds (FEV6), and forced expiratory flow at 25‑75% of vital capacity (FEF25‑75) determine small airway disease, and how do they correlate with impulse oscillometry parameters (e.g., resistance at 5 Hz (R5), resistance at 20 Hz (R20), R5‑R20 difference, reactance at 5 Hz (X5), and area of reactance (AX))?
How is chronic obstructive pulmonary disease (COPD) diagnosed and its severity graded, including post‑bronchodilator spirometry criteria, percent predicted FEV1, symptom burden, exacerbation history, and GOLD group (A‑D) classification?
In a patient with a post‑bronchodilator FEV1/FVC ratio below 70%, documented bronchodilator reversibility, long‑term cigarette smoking, wheezing and dyspnea, does this indicate asthma‑COPD overlap?
What is the best course of action for a patient with chronic chest discomfort, lung pain, normal DLCO, elevated FVC, and decreased FEV1/FVC ratio, suggestive of obstructive lung disease?
A patient took oral hydralazine 25 mg 7.5 hours ago and amlodipine besylate 5 mg plus valsartan 80 mg 6 hours ago; when should the next doses be given and what medications should be included?
What are the differential diagnoses for a maculopustular lesion on the proximal phalanx of the hand?
What is the likely diagnosis and recommended work‑up for a solitary 5‑mm maculopustular papule on the dorsal proximal phalanx with no other skin involvement?
What are the current emergency and intensive care management guidelines for adult patients with traumatic brain injury?
Could the solitary 5‑mm maculopustular papule on the dorsal proximal phalanx represent herpetic whitlow?
What are the causes of diverticulitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question